BioCardia (BCDA) Invested Capital (2010 - 2022)

BioCardia (BCDA) has reported Invested Capital for 9 consecutive years, with $4.9 million the latest figure, recorded in Q4 2022.

• On a quarterly basis, Invested Capital fell 52.67% year-over-year to $4.9 million in Q4 2022; TTM through Dec 2022 was $4.9 million, a 52.67% decrease from a year earlier, with the FY2022 full-year figure at $4.9 million, down 52.67% from the prior year.
• Invested Capital was $4.9 million for Q4 2022 at BioCardia, up from $4.1 million in the prior quarter.
• Over five years, Invested Capital peaked at $10.4 million in Q4 2021 and troughed at $3.0 million in Q3 2018.
• A 4-year average of $6.2 million and a median of $5.8 million in 2018 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital tumbled 78.14% in 2018 and tumbled 52.67% in 2022, its largest moves.
• Over 4 years, Invested Capital stood at $3.0 million in 2018, then soared by 52.69% to $4.6 million in 2020, then soared by 124.47% to $10.4 million in 2021, then plunged by 52.67% to $4.9 million in 2022.
• The last three Invested Capital figures came in at $4.9 million (Q4 2022), $4.1 million (Q3 2022), and $6.8 million (Q2 2022), per Business Quant data.